Skip to main content
Future Journal of Pharmaceutical Sciences

Table 8 Results of % assay of the tablet dosage form

From: An effective stability indicating RP-HPLC method for simultaneous estimation of Dolutegravir and Lamivudine in bulk and their tablet dosage form

Drug

Peak name

RT

Peak area

USP tailing

USP plate count

Label claim (mg)

%assay

Dolutegravir

Standard

5.068

4185447

1.05

9023

50

99.5

Test

5.065

4131307

1.05

9923

 

Lamivudine

Standard

3.349

10699768

1.05

9923

300

99.64

Test

3.34

10713746

1.06

10022

  1. Average wt of the tablet 401 mg, % purity of Lamivudine standard (API) 99.3, and % purity of Dolutegravir standard (API) 99.4
Back to article page